YGS40, an active fraction of Yi-Gan San, reduces hydrogen peroxide-induced apoptosis in PC12 cells

https://doi.org/10.1016/S1875-5364(15)30037-6Get rights and content

Abstract

In our previous study, we have elucidated the chemical profile of YGS40, a fraction of Yi-Gan San (YGS), used for the treatment of Alzheimer's disease (AD). Oxidative stress-induced apoptosis is implicated in neurodegenerative disorders such as AD. The aim of the present study was to explore the protective effects of YGS40 against hydrogen peroxide (H2O2)-induced apoptosis in PC12 cells and the underlying mechanisms. PC12 cells were exposed to 100 μmol·L−1 of H2O2 for 12 h with or without YGS40 pretreatment. Cytotoxicity was determined by MTT (3, (4, 5-dimethylthiazole-2-yl) 2, 5-diphenyl-tetrazolium bromide) and lactate dehydrogenase (LDH) release assays; apoptosis was detected by Annexin V/propidium iodide coupled staining and by determining caspase-3 activity and Bax and Bcl-2 protein levels. Mitochondrial membrane potential (MMP) was assessed by the retention of rhodamine123; and the activities of superoxide dismutase (SOD) and malondialdehyde (MDA) were measured using commercially available enzymatic kits. Pretreatment with YGS40 significantly prevented H2O2-induced cytotoxicity and protected the cells against H2O2-triggered apoptosis characterized by externalization of membrane phosphatidylserine and caspase-3 activation and the increased ratio of Bax/Bcl-2 in PC12 cells. Further studies showed that YGS40 suppressed H2O2-induced MMP loss, increased SOD activity, and decreased MDA level. These findings suggest that YGS40 may be beneficial for the prevention and treatment of oxidative stress-mediated disorders.

Previously we have elucidated the chemical profile of YGS40. In this study, we investigated the protective effects of YGS40 on H2O2-induce apoptosis in PC12 cells. The results showed that YGS40 could prevent H2O2-induced apoptosis, which is implicated in neurodegenerative disorders such as Alzheimer's disease. These findings suggest that YGS40 may be beneficial for the prevention and treatment of oxidative stress-induced disorders.

  1. Download : Download full-size image

References (24)

Cited by (9)

  • Synthesis and biological evaluation of scutellarein derivatives as neuroprotective agents via activating Nrf2/HO-1 pathway

    2022, Fitoterapia
    Citation Excerpt :

    These target compounds were purified by column chromatography, and identified by 1H NMR, 13C NMR and high-resolution mass spectrometry. H2O2 is the main intracellular ROS that can cause protein degradation, aggregation, lipid peroxidation, and DNA damage, eventually accelerating oxidative injury and neuronal cell death [41,42]. Thus, the neuroprotective effects of all target compounds with different concentration (2, 10, 20 μM) on SH-SY5Y cells damaged by H2O2 was detected by CCK-8 assay.

  • Non-VMAT2 inhibitor treatments for the treatment of tardive dyskinesia

    2018, Journal of the Neurological Sciences
    Citation Excerpt :

    One of its components, Uncaria sinensis, also has been shown to prevent neuronal death induced by glutamate, possibly by inhibiting Ca2+ influx [78]. YGS40, an active component of yi-gan san, also reduces apoptosis triggered by hydrogen-peroxide [79]. An open-label study with 22 TD patients showed significant reduction of AIMS scores from baseline (12.1 ± 2.2 to 1.6 ± 1.3, p < 0.0001) after 12-week treatment of 7.5 g/day of yi-gan san [80].

  • Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease

    2016, Bioorganic and Medicinal Chemistry
    Citation Excerpt :

    − 0.2915 (R2 = 0.9260) (Supporting information, Fig. S1). The cytotoxicity effect of test compound on the human neuroblastoma SH-SY5Y cells was evaluated by MTT assay according to a described methods.57,58 The SH-SY5Y cells were grown in a 1:1 mixture of Eagle’s minimum essential medium (EMEM) and ham’s F-12 medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin in 5% CO2 at 37 °C.

  • Pathophysiology, prognosis and treatment of tardive dyskinesia

    2022, Therapeutic Advances in Psychopharmacology
View all citing articles on Scopus

Available online 20 June 2015

Research funding This work was supported by the National Natural Science Foundation of China (Nos. 81274046 and 81373956).

These authors have no conflict of interest to declare.

View full text